Economy · Finance
A pharma giant is moving past one patent cliff — but another is already looming
CNBC · World
Published 30 Oct 2026, 5:00 pm·1 h ago·1 min read
Listen to this story
Read aloud by your device
Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.
Read the full story at CNBC · World
cnbc.com